New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis.
Khanna D, Huang S, Lin CJF, Spino C.
Ann Rheum Dis. 2021 May;80(5):641-650. doi: 10.1136/annrheumdis-2020-219100. Epub 2020 Nov 30.
CD19-targeting CAR T-cell therapy in patients with diffuse systemic sclerosis: a case series.
Auth J, Müller F, Völkl S, Bayerl N, Distler JHW, Tur C, Raimondo MG, Chenguiti Fakhouri S, Atzinger A, Coppers B, Eckstein M, Liphardt AM, Bäuerle T, Tascilar K, Aigner M, Kretschmann S, Wirsching A, Taubmann J, Hagen M, Györfi AH, Kharboutli S, Krickau T, Dees C, Spörl S, Rothe T, Harrer T, Bozec A, Grieshaber-Bouyer R, Fuchs F, Kuwert T, Berking C, Horch RE, Uder M, Mackensen A, Schett G, Bergmann C.
Lancet Rheumatol. 2025 Feb;7(2):e83-e93. doi: 10.1016/S2665-9913(24)00282-0. Epub 2024 Nov 11.
Skin involvement in early diffuse cutaneous systemic sclerosis: an unmet clinical need.
Herrick AL, Assassi S, Denton CP.
Nat Rev Rheumatol. 2022 May;18(5):276-285. doi: 10.1038/s41584-022-00765-9. Epub 2022 Mar 15.
Rituximab in diffuse cutaneous systemic sclerosis: should we be using it today?
McQueen FM, Solanki K.
Rheumatology (Oxford). 2015 May;54(5):757-67. doi: 10.1093/rheumatology/keu463. Epub 2015 Jan 7.
Treatment of early diffuse systemic sclerosis skin disease.
Frech TM, Shanmugam VK, Shah AA, Assassi S, Gordon JK, Hant FN, Hinchcliff ME, Steen V, Khanna D, Kayser C, Domsic RT.
Clin Exp Rheumatol. 2013 Mar-Apr;31(2 Suppl 76):166-71. Epub 2013 Jul 23.
Diffuse systemic sclerosis.
CULLINAN ER.
Acta Med Scand Suppl. 1956;312:465-6. doi: 10.1111/j.0954-6820.1956.tb17039.x.
Single-cell analysis reveals key differences between early-stage and late-stage systemic sclerosis skin across autoantibody subgroups.
Clark KEN, Xu S, Attah M, Ong VH, Buckley CD, Denton CP.
Ann Rheum Dis. 2023 Dec;82(12):1568-1579. doi: 10.1136/ard-2023-224184. Epub 2023 Aug 14.
Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis.
Gaydosik AM, Tabib T, Domsic R, Khanna D, Lafyatis R, Fuschiotti P.
Ann Rheum Dis. 2021 Nov;80(11):1453-1460. doi: 10.1136/annrheumdis-2021-220209. Epub 2021 May 24.
Phenotype of diffuse cutaneous systemic sclerosis patients with positive anticentromere antibodies: A systematic literature review and meta-analysis.
Binda M, Ortolan A, Moccaldi B, Salvato M, Cuberli A, Padoan R, Doria A, Zanatta E.
Semin Arthritis Rheum. 2025 Feb;70:152606. doi: 10.1016/j.semarthrit.2024.152606. Epub 2024 Dec 3.
[Diffuse hyperpigmentation in systemic sclerosis].
Burmann SN, Matull J, Oellig F, Distler JHW, Kreuter A, Györfi AH.
Dermatologie (Heidelb). 2025 Jun;76(6):373-376. doi: 10.1007/s00105-025-05494-0. Epub 2025 Mar 26.
